The estimated Net Worth of Seymour Liebman is at least $257 Тысяча dollars as of 15 September 2023. Mr. Liebman owns over 2,300 units of T2 Biosystems Inc stock worth over $16,105 and over the last 8 years he sold TTOO stock worth over $0. In addition, he makes $240,404 as Director at T2 Biosystems Inc.
Seymour has made over 6 trades of the T2 Biosystems Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 2,300 units of TTOO stock worth $5,290 on 15 September 2023.
The largest trade he's ever made was exercising 73,224 units of T2 Biosystems Inc stock on 25 June 2022 worth over $168,415. On average, Seymour trades about 13,381 units every 90 days since 2016. As of 15 September 2023 he still owns at least 7,002 units of T2 Biosystems Inc stock.
You can see the complete history of Mr. Liebman stock trades at the bottom of the page.
Seymour E. Liebman serves as Director of the Company. He has served as a member of our Board of Directors since September 2016. Mr. Liebman has been employed by Canon USA, Inc., a leading provider of consumer, business-to-business, and industrial imaging solutions to the United States and to Latin America and the Caribbean markets, since 1974 and currently serves as its Executive Vice President, Chief Administrative Officer and General Counsel and Senior Managing Executive Officer of Canon Inc., Japan. Mr. Liebman received his J.D. from Touro Law School, his M.S. in mathematics from Rutgers University, his M.S. in accounting from Long Island University and his B.A. in mathematics from Hofstra University.
As the Director of T2 Biosystems Inc, the total compensation of Seymour Liebman at T2 Biosystems Inc is $240,404. There are 5 executives at T2 Biosystems Inc getting paid more, with John McDonough having the highest compensation of $1,637,480.
Seymour Liebman is 71, he's been the Director of T2 Biosystems Inc since 2019. There are 2 older and 16 younger executives at T2 Biosystems Inc. The oldest executive at T2 Biosystems Inc is John Cumming, 74, who is the Lead Independent Director.
Seymour's mailing address filed with the SEC is 101, Hartwell Avenue, Lexington, Middlesex County, Massachusetts, 02421, United States.
Over the last 10 years, insiders at T2 Biosystems Inc have traded over $18,971,153 worth of T2 Biosystems Inc stock and bought 5,875,341 units worth $59,722,018 . The most active insiders traders include Adrian M Jones, Group L.P.Crg Partners Iii ... и Thomas J. Carella. On average, T2 Biosystems Inc executives and independent directors trade stock every 20 days with the average trade being worth of $764,499. The most recent stock trade was executed by John J Iii Sperzel on 24 February 2024, trading 67 units of TTOO stock currently worth $154.
t2 biosystems is developing innovative diagnostic products to improve patient health. with two fda-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, t2 biosystems is an emerging leader in the field of in vitro diagnostics. our initial development efforts target sepsis, hemostasis, bacteria and lyme disease, which are areas of significant unmet medical need. the company is utilizing its proprietary t2 magnetic resonance platform, or t2mr®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. at t2 biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. we invite you to apply for one of our open positions at www
T2 Biosystems Inc executives and other stock owners filed with the SEC include: